ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
99 619,90
-1,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Lisata Therapeutics Inc (LSTA) Cours

Lisata Therapeutics Inc

Lisata Therapeutics Inc (LSTA)

NASDAQ
2,5005
-0,0895
(-3,46%)
Fermé 02 Février 10:00PM
Retardé de 15 minutes
2,5005
0,00
(0,00%)
Après les heures de négociation: 12:21AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
2,5005
Prix Achat
2,50
Prix Vente
2,65
Volume échangé
5 469
2,48 Fourchette du Jour 2,6951
2,19 Plage de 52 semaines 4,20
Cap du marché
20,991M
Clôture Veille
2,59
Ouverture
2,598
Dernière Transaction
1
@
2.51
Dernière heure de transaction
Volume financier
US$ 13 935
VWAP
2,548
Volume moyen (3 m)
41 331
Actions en circulation
8 394 903
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,01
Bénéfice par action (BPA)
-2,48
Chiffre d'affairess
-
Bénéfice net
-20,84M

À propos de Lisata Therapeutics Inc

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Secteur
Health & Allied Services,nec
Industrie
Insurance Carriers, Nec
Site Web
www.caladrius.com
Siège social
Wilmington, Delaware, USA
Fondé
2006
Lisata Therapeutics Inc est coté dans le secteur Health & Allied Services de la NASDAQ avec le ticker LSTA. Le dernier cours de clôture d'Lisata Therapeutics était de US$2,59. Au cours de la dernière année, les actions de Lisata Therapeutics ont été négociées dans une fourchette de prix de US$ 2,19 à US$ 4,20.

Lisata Therapeutics compte actuellement 8 394 903 actions en circulation. La capitalisation boursière d'Lisata Therapeutics est de US$21,74 million. Lisata Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.01.

LSTA Dernières nouvelles

Plus de nouvelles

Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

Data corroborate previously reported preclinical data demonstrating certepetide’s ability to enhance the effectiveness of immunotherapy Preliminary results to be presented at the 2025 ASCO...

23 Janvier 2025
GlobeNewswire Inc.

Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

Cohort A data to be presented in a poster session at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium Data reported positive trend in overall survival, including...

22 Janvier 2025
GlobeNewswire Inc.

Lisata Therapeutics to Present at the 2025 Sequire Investor Summit

BASKING RIDGE, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the...

15 Janvier 2025
GlobeNewswire Inc.

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

BASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the...

10 Décembre 2024
GlobeNewswire Inc.

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

BASKING RIDGE, N.J. and HOUSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies...

03 Décembre 2024
GlobeNewswire Inc.

Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’

Award recognizes Lisata’s data-driven approach and innovative therapies designed to address the unmet medical needs of patients with advanced solid tumors Annual BioTech Breakthrough Award is...

19 Novembre 2024
GlobeNewswire Inc.

Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Robust and expanding development portfolio with multiple key data readouts projected over the next 18 months Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J...

12 Novembre 2024
GlobeNewswire Inc.

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

BASKING RIDGE, N.J. and HELSINKI, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the...

06 Novembre 2024
GlobeNewswire Inc.

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

BASKING RIDGE, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of...

06 Novembre 2024
GlobeNewswire Inc.

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

BASKING RIDGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of...

31 Octobre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.10054.18752.42.952.4425762.63348537CS
4-1.1295-31.11570247933.634.22.4876583.39649052CS
12-0.3545-12.41681260952.8554.22.19413313.22932698CS
26-0.8295-24.90990990993.334.22.19247163.16323529CS
52-0.1295-4.923954372622.634.22.19199023.1865163CS
156-6.2995-71.58522727278.89.381.95235953.69491547CS
260-6.2995-71.58522727278.89.381.95235953.69491547CS

LSTA - Frequently Asked Questions (FAQ)

What is the current Lisata Therapeutics share price?
The current share price of Lisata Therapeutics is US$ 2,5005
How many Lisata Therapeutics shares are in issue?
Lisata Therapeutics has 8 394 903 shares in issue
What is the market cap of Lisata Therapeutics?
The market capitalisation of Lisata Therapeutics is USD 21,74M
What is the 1 year trading range for Lisata Therapeutics share price?
Lisata Therapeutics has traded in the range of US$ 2,19 to US$ 4,20 during the past year
What is the PE ratio of Lisata Therapeutics?
The price to earnings ratio of Lisata Therapeutics is -1,01
What is the reporting currency for Lisata Therapeutics?
Lisata Therapeutics reports financial results in USD
What is the latest annual profit for Lisata Therapeutics?
The latest annual profit of Lisata Therapeutics is USD -20,84M
What is the registered address of Lisata Therapeutics?
The registered address for Lisata Therapeutics is 651 N BROAD ST SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19709
What is the Lisata Therapeutics website address?
The website address for Lisata Therapeutics is www.caladrius.com
Which industry sector does Lisata Therapeutics operate in?
Lisata Therapeutics operates in the INSURANCE CARRIERS, NEC sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
731,1M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,87M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,57M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,58M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,91M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,93k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
900,48k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,42M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
731,1M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,5M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
341,8M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
237,15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LSTA
Lisata Therapeutics
NASDAQI
SX303010PI
OMX Stockholm Life Insur...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces